Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reimmunization after allogeneic bone marrow transplantation

J Somani1, R A Larson

  • 1Department of Medicine, University of Chicago, Illinois, USA.

The American Journal of Medicine
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empowerment of nurses in antibiotic stewardship: a social ecological qualitative analysis.

The Journal of hospital infection·2020
Same author

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020
Same author

Histoplasmosis presenting with Sweet's syndrome.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Treatment of horizontal silage bunker runoff using biochar amended vegetative filter strips.

Journal of environmental management·2019
Same author

Nitrate sorption to biochar following chemical oxidation.

The Science of the total environment·2019
Same author

Constraining the Spatial Extent of Marine Oil Snow Sedimentation and Flocculent Accumulation Following the Deepwater Horizon Event Using an Excess <sup>210</sup>Pb Flux Approach.

Environmental science & technology·2017
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Reimmunization after allogeneic bone marrow transplant is crucial for restoring immunity. Guidelines are presented for optimal vaccine timing and methods to improve patient outcomes and reduce infection risk.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Infectious Disease

Background:

  • Allogeneic bone marrow transplant recipients face prolonged immunocompromise and infection risk.
  • The effectiveness of reimmunization strategies in these patients remains unclear.
  • Immune system components mature at different rates post-transplant, impacting infection susceptibility.

Purpose of the Study:

  • To review current concepts of immune reconstitution after bone marrow transplantation.
  • To evaluate the immunogenicity of various vaccines in transplant recipients.
  • To provide guidelines for a reimmunization schedule in allogeneic bone marrow transplant patients.

Main Methods:

  • Literature review of immune reconstitution and vaccine responses in bone marrow transplant patients.

Related Experiment Videos

  • Analysis of antibody seronegativity and vaccine efficacy based on antigen type (polysaccharide, protein conjugate).
  • Assessment of factors influencing immune response, such as graft-versus-host disease.

    • Main Results:

    • Most patients achieve adequate antibody titers to vaccines given 12 months post-transplant, unless chronic graft-versus-host disease is present.
    • Protein and polysaccharide-protein conjugate vaccines (e.g., tetanus, Hib) are more immunogenic than polysaccharide vaccines (e.g., pneumococcal).
    • Standard vaccines are generally supported, but optimal timing and methods require further investigation.

    Conclusions:

    • Reimmunization is supported by literature, with protein-conjugate vaccines showing promise.
    • Graft-versus-host disease can impair vaccine response.
    • Further research is needed to optimize reimmunization protocols for bone marrow transplant recipients.